|Videos|June 29, 2022
Future Perspectives in Renal Cell Carcinoma (RCC)
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer
2
Experts Highlight Notable Advances in Colorectal Cancer at 2025 ESMO
3
FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia
4
Breaking Down Advancements in Prostate Cancer Care
5
